loadpatents
name:-0.014126062393188
name:-0.014494895935059
name:-0.0051188468933105
Azevan Pharmaceuticals, Inc. Patent Filings

Azevan Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Azevan Pharmaceuticals, Inc..The latest application filed is for "compositions and methods for treating brain injury".

Company Profile
5.16.13
  • Azevan Pharmaceuticals, Inc. - Bethlehem PA
  • Azevan Pharmaceuticals, Inc - Bethlehem PA
  • Azevan Pharmaceuticals, Inc. -
  • Azevan Pharmaceuticals, Inc. - 115 Research Drive Bethlehem PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions and methods for treating neurodegenerative diseases
Grant 11,319,306 - Brownstein May 3, 2
2022-05-03
Methods for treating post traumatic stress disorder
Grant 10,953,001 - Brownstein March 23, 2
2021-03-23
Compositions And Methods For Treating Brain Injury
App 20200276167 - BROWNSTEIN; Michael J.
2020-09-03
Compositions And Methods For Treating Neurodegenerative Diseases
App 20200102294 - BROWNSTEIN; Michael J.
2020-04-02
Compositions and methods for treating neurodegenerative diseases
Grant 10,364,236 - Brownstein
2019-07-30
Methods For Treating Post Traumatic Stress Disorder
App 20190099410 - BROWNSTEIN; Michael J.
2019-04-04
Compositions And Methods For Treating Neurodegenerative Diseases
App 20180201608 - BROWNSTEIN; Michael J.
2018-07-19
Methods for treating post traumatic stress disorder
Grant 9,987,265 - Brownstein June 5, 2
2018-06-05
Compositions and methods for treating neurodegenerative diseases
Grant 9,802,925 - Brownstein October 31, 2
2017-10-31
Compositions And Methods For Treating Neurodegenerative Diseases
App 20170174670 - BROWNSTEIN; Michael J.
2017-06-22
Beta-lactamylalkanoic acids for treating premenstrual disorders
Grant 9,597,314 - Koppel , et al. March 21, 2
2017-03-21
Methods For Treating Post Traumatic Stress Disorder
App 20160339006 - BROWNSTEIN; Michael J.
2016-11-24
Methods for treating post traumatic stress disorder
Grant 9,376,424 - Brownstein June 28, 2
2016-06-28
Methods For Treating Post Traumatic Stress Disorder
App 20130109666 - Brownstein; Michael J.
2013-05-02
.beta.-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
Grant 8,426,400 - Koppel , et al. April 23, 2
2013-04-23
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
Grant 8,048,874 - Koppel , et al. November 1, 2
2011-11-01
Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS
App 20110059935 - Bruns, JR.; Robert F. ;   et al.
2011-03-10
Beta-lactamylalkanoic Acids For Treating Premenstrual Disorders
App 20090170825 - Koppel; Gary A. ;   et al.
2009-07-02
Beta-Lactamyl Phenylalanine, Cysteine, and Serine Vasopressin Antagonists
App 20080280870 - Koppel; Gary A. ;   et al.
2008-11-13
{Beta}-Lactamyl vasopression V1a antagonists and methods of use
App 20080113959 - Koppel; Gary A.
2008-05-15
{Beta}-Lactamyl vasopression V1a antagonists and methods of use
App 20080090797 - Koppel; Gary A. ;   et al.
2008-04-17
.beta.-lactamyl vasopressin V.sub.1a antagonists
Grant 7,268,125 - Bruns, Jr. , et al. September 11, 2
2007-09-11
.beta.-Lactamyl vasopressin V.sub.1a Antagonists
Grant 7,119,083 - Bruns, Jr. , et al. October 10, 2
2006-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed